Research Area 1: Translational Studies and Mechanisms of Disease in Infectious Diseases and Sepsis
Our research programmes focus on understanding mechanisms of disease, molecular Omics and immunology of sepsis and infectious diseases. Our discoveries will lead to applications in molecular classification, screening, prevention, detection, diagnostics, prognostics and therapeutics.
We plan to perform comprehensive molecular profiling and integrative genomic and immunological studies on a large series of patients with infectious diseases and sepsis. We will develop and validate pathways using next-generation sequencing, expression microarray, methylation array and DNA SNP genotyping array. The discovery of novel biomarkers using slow, complex biotechnology may then be evaluated for rapid point of care tests.
This new initiative is seeking Theme-Based Research Scheme (TBRS) funding, angel investors as well as partnerships with major pharmaceutical and diagnostic companies.
| Supervisor(s) |
|---|
Research Area 2: Translational Studies and Mechanisms of Disease in Stroke
Our research programme focuses on early biomarker discoveries in Stroke in the emergency department. An understanding of the molecular Omics and immunology of stroke will lead to applications in molecular classification, screening, prevention, detection, diagnostics, prognostics and therapeutics.
Our team in Hong Kong will pioneer a translational programme focusing on the potential for circulating biomarkers as diagnostic and prognostic markers in patients with stroke.
We plan to perform comprehensive molecular profiling, integrative omics and immunological studies on patients with stroke and to develop and validate pathways using Omics approaches. The discovery of novel biomarkers using biotechnology may then be evaluated for rapid point of care tests.
| Supervisor(s) |
|---|
Research Area 3: Epidemiology, Prediction and Translational Studies in Acute Kidney Injury
Our research programme focuses on the underlying clinical and molecular epidemiology of acute kidney injury with the aim of developing pragmatic and clinically relevant prediction tools. Our team in Hong Kong will pioneer a translational programme focusing on the potential for circulating biomarkers as diagnostic and prognostic markers in patients with acute kidney injury. We plan to use our clinical and molecular discoveries to develop and validate diagnostic and prognostic tools in clinical practice.
| Supervisor(s) |
|---|
Find Out More
Information on selected projects or research areas: Interested candidates are advised to email the relevant supervisors. Please enclose with your email: (i) your CV, (ii) a brief description of your research interest and experience, and (iii) two reference letters (reference letters not required for HKUMed UG students seeking MRes[Med] or URIS projects)
Information on the research programme, funding support and admission requirements could be found on the RPg Admissions website.
General admission enquiries should be directed to rpgmed@hku.hk.
Follow HKUMed